NDSI
TCRR
Newman Dignan & Sheerar Inc’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-12,522
| Closed | -$18.8K | – | 198 |
|
2023
Q1 | $18.8K | Hold |
12,522
| – | – | 0.01% | 191 |
|
2022
Q4 | $12.5K | Buy |
12,522
+1,000
| +9% | +$999 | ﹤0.01% | 188 |
|
2022
Q3 | $21 | Buy |
+11,522
| New | +$21 | ﹤0.01% | 179 |
|
2022
Q2 | – | Sell |
-11,023
| Closed | -$30 | – | 211 |
|
2022
Q1 | $30 | Buy |
+11,023
| New | +$30 | 0.01% | 192 |
|